Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fresenius Medical Care AG & Co. KGaA (DE:FME)
XETRA:FME
RESEARCH TOOLSreports
Holding DE:FME?
Track your performance easily
See the Price Targets and Ratings of:
FME Analyst Ratings
Hold
2 Buy
8 Hold
4 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
FME Stock 12 Month Forecast
Average Price Target
€41.91
▲(2.34% Upside)
| Highest Price Target€78.00 | Average Price Target€41.91 | Lowest Price Target€29.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Goldman Sachs
Reiterated
11/18/24
Barclays
Reiterated
11/07/24
Deutsche Bank
Reiterated
11/06/24
Berenberg Bank
Reiterated
11/05/24
Bernstein
Reiterated
11/05/24
Warburg Research
Reiterated
11/05/24
Jefferies
Reiterated
11/05/24
J.P. Morgan
Reiterated
11/05/24
Kepler Capital
Reiterated
11/05/24
Citi
€40→€41
Hold
0.12%
Upside
Reiterated
10/23/24
Fresenius Medical Care AG #x26; Co KGaA (FME:GR) (FMS) PT Raised to EUR41 at CitiCiti analyst Veronika Dubajova raised the price target on Fresenius Medical Care AG Co KGaA (FME:GR) (NYSE: FMS) to EUR41.00 (from EUR40.00) while maintaining a Neutral rating.
Bank of America Securities
€30→€33
Sell
-19.41%
Downside
Reiterated
10/22/24
Sell Rating for Fresenius Medical Care Due to Weak Growth and Margin Pressures
Morgan Stanley
€33→€34
Sell
-16.97%
Downside
Reiterated
02/23/24
Fresenius Medical Care AG #x26; Co KGaA (FME:GR) (FMS) PT Raised to EUR34 at Morgan StanleyMorgan Stanley analyst Robert Davies raised the price target on Fresenius Medical Care AG Co KGaA (FME:GR) (NYSE: FMS) to EUR34.00 (from EUR33.00) while maintaining a Underweight rating.
HSBC
€38→€39
Hold
-4.76%
Downside
Upgraded
11/24/23
Fresenius Medical upgraded to Hold from Reduce at HSBCFresenius Medical upgraded to Hold from Reduce at HSBC
―
Nomura
―
Hold
―
Reiterated
11/08/24
Flexium Interconnect (6269:TT) (FMS) PT Lowered to EUR78 at Nomura/InstinetNomura/Instinet analyst Ann Lee lowered the price target on Flexium Interconnect (6269:TT) (NYSE: FMS) to EUR78.00 (from EUR90.00) while maintaining a Neutral rating.
Best Analysts Covering Fresenius Medical Care AG & Co. KGaA
Which Analyst Should I Follow If I Want to Buy DE:FME and Sell After:
1 Month
xxx
Success Rate
22/49 ratings generated profit
Average Return
-1.32%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 44.90% of your transactions generating a profit, with an average return of -1.32% per trade.
3 Months
xxx
Success Rate
21/49 ratings generated profit
Average Return
+0.50%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +0.50% per trade.
1 Year
Success Rate
17/37 ratings generated profit
Average Return
-1.28%
reiterated a sell rating 16 days ago
Copying James Vane's trades and holding each position for 1 Year would result in 45.95% of your transactions generating a profit, with an average return of -1.28% per trade.
2 Years
xxx
Success Rate
15/37 ratings generated profit
Average Return
-3.79%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 40.54% of your transactions generating a profit, with an average return of -3.79% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
FME Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
0
0
0
0
0
Buy
9
5
5
2
5
Hold
13
8
7
2
10
Sell
14
9
11
12
13
Strong Sell
0
0
0
0
0
total
36
22
23
16
28
Each month's total comprises the sum of three months' worth of ratings.
FME Financial Forecast
FME Stock Forecast FAQ
What is DE:FME’s average 12-month price target, according to analysts?
Based on analyst ratings, Fresenius Medical Care AG & Co. KGaA’s 12-month average price target is €41.91.
What is DE:FME’s upside potential, based on the analysts’ average price target?
Fresenius Medical Care AG & Co. KGaA has 2.34% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Fresenius Medical Care AG & Co. KGaA a Buy, Sell or Hold?
Fresenius Medical Care AG & Co. KGaA has a consensus rating of Hold, which is based on 2 buy ratings, 8 hold ratings and 4 sell ratings.
What is Fresenius Medical Care AG & Co. KGaA’s share price target?
The average share price target for Fresenius Medical Care AG & Co. KGaA is €41.91. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €78.00 ,and the lowest forecast is €29.00. The average share price target represents 2.34% Increase from the current price of €40.95.
The highest analyst share price target is €78.00 ,and the lowest forecast is €29.00. The average share price target represents 2.34% Increase from the current price of €40.95.
What do analysts say about Fresenius Medical Care AG & Co. KGaA?
Fresenius Medical Care AG & Co. KGaA’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of Fresenius Medical Care AG & Co. KGaA?
To buy shares of DE:FME, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.